Mark E. Pepin
Impact in
-
- Cardiovascular Function and Risk Factors
-
- Diabetes Treatment and Management
Papers in
-
- Epigenetics and DNA Methylation 5
- Metabolism, Diabetes, and Cancer 3
-
- Cardiovascular Function and Risk Factors 7
- Heart Failure Treatment and Management 4
- Co-authors
- Adam R. Wende (19 shared papers)Manoja K. Brahma (5 shared papers)Chae‐Myeong Ha (4 shared papers)Rajat M. Gupta (3 shared papers)Stavros G. Drakos (2 shared papers)Mark E. Roberts (1 shared paper)Bruce C. Bunker (1 shared paper)Dale L. Huber (1 shared paper)
- Journals
- American Journal of Physiology-Heart and Circulatory Physiology (4 papers)Basic Research in Cardiology (3 papers)Circulation Research (2 papers)Advanced Materials (1 paper)Molecular Metabolism (1 paper)
- Partner nations
- United StatesGermanyItaly
In The Last Decade
Mark E. Pepin
35 papers receiving 802 citations
Peers
Comparison fields: 5 of 94
- Cardiology and Cardiovascular Medicine 164
- Endocrinology, Diabetes and Metabolism 119
- Physiology 136
- Molecular Biology 307
- Aging 6
Countries citing papers authored by Mark E. Pepin
This map shows the geographic impact of Mark E. Pepin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark E. Pepin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark E. Pepin more than expected).
Fields of papers citing papers by Mark E. Pepin
This network shows the impact of papers produced by Mark E. Pepin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark E. Pepin. The network helps show where Mark E. Pepin may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark E. Pepin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 39 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 78 | |
| 2 | 2018 | 76 | |
| 3 | 2019 | 63 | |
| 4 | 2012 | 62 | |
| 5 | 2013 | 57 | |
| 6 | 2020 | 54 | |
| 7 | 2017 | 47 | |
| 8 | 2017 | 47 | |
| 9 | 2023 | 37 | |
| 10 | 2021 | 35 | |
| 11 | 2017 | 31 | |
| 12 | 2017 | 29 | |
| 13 | 2021 | 21 | |
| 14 | 2019 | 19 | |
| 15 | 2021 | 18 | |
| 16 | 2018 | 18 | |
| 17 | 2020 | 17 | |
| 18 | 2025 | 12 | |
| 19 | 2019 | 12 | |
| 20 | 2023 | 11 |
About Mark E. Pepin
Mark E. Pepin is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine, Surgery, Public Health, Environmental and Occupational Health and Endocrinology, Diabetes and Metabolism, having authored 39 papers that have together received 809 indexed citations. Recurring topics across this work include Cardiovascular Function and Risk Factors (7 papers), Epigenetics and DNA Methylation (5 papers), Health and Medical Research Impacts (4 papers), Heart Failure Treatment and Management (4 papers), Pancreatic function and diabetes (4 papers), Diabetes Treatment and Management (3 papers), Metabolism, Diabetes, and Cancer (3 papers) and Diet and metabolism studies (3 papers). The work is most often cited by research in Cardiology and Cardiovascular Medicine (164 citations), Endocrinology, Diabetes and Metabolism (119 citations), Physiology (136 citations), Molecular Biology (307 citations) and Aging (6 citations). Mark E. Pepin has collaborated with scholars based in United States, Germany and Italy. Frequent co-authors include Adam R. Wende, Manoja K. Brahma, Chae‐Myeong Ha, Rajat M. Gupta, Stavros G. Drakos, Mark E. Roberts, Bruce C. Bunker, Dale L. Huber, Keith Baar and Amy Patton. Their work appears in journals such as American Journal of Physiology-Heart and Circulatory Physiology, Basic Research in Cardiology, Circulation Research, Advanced Materials and Molecular Metabolism.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.